Ce diaporama a bien été signalé.
Nous utilisons votre profil LinkedIn et vos données d’activité pour vous proposer des publicités personnalisées et pertinentes. Vous pouvez changer vos préférences de publicités à tout moment.

Treatment for alopecia

130 vues

Publié le

Whiteboard2Boardroom collaborates with more than 21 research institutions, hospitals and corporation to move technologies out of research labs into the marketplace.

Publié dans : Santé
  • Profollica�'s all-natural formula helped 90% of men reduce hair loss in a clinical trial. ■■■ https://tinyurl.com/y49r9d8j
    Voulez-vous vraiment ?  Oui  Non
    Votre message apparaîtra ici
  • Soyez le premier à aimer ceci

Treatment for alopecia

  1. 1. Treatment for Alopecia May 30, 2019
  2. 2. What is the problem? – Androgenetic alopecia (hair loss), affecting up to 70% of men and 40% of women. – American hair loss sufferers spend more than 3.5 billion dollars a year in an attempt to treat their hair loss. – An estimated 310,624 surgical hair restoration procedures were performed worldwide in 2012 (a 10% increase from 2010). – US had the most at 88,304 hair restoration procedures performed – Worldwide market for hair restoration is 2 billion dollars. Presenter: Aswini K. Betha, PhD
  3. 3. How does product/service solve problem? –Novel formulation that increases hair growth. –To treat pattern baldness in men and women –To treat hair loss induced by chemotherapy in cancer survivors. –Safe and painless topical formulation. Presenter: Aswini K. Betha, PhD
  4. 4. What is the market use? Presenter: Aswini K. Betha, PhD • Safe, painless, effective and easy to apply scalp application (non-invasive). • Safe and painless topical formulation. • Alternative for hair transplantation. • No adverse effects at high doses. • Can replace the currently ineffective and painful treatments.
  5. 5. What competition exists? • May work better than Minoxidil. –Minoxidil does not work for most patients: • 15% will experience some sort of hair regrowth. • 50% have their hair loss delayed. • 35% will continue to lose hair. Presenter: Aswini K. Betha, PhD
  6. 6. What is the status of the intellectual property? • Patents issued in US: – US Issued Patent # 7,825,217 – US Issued Patent # 10,213,479 • Additional patents pending Presenter: Aswini K. Betha, PhD
  7. 7. What is the stage of development? • Animal Experiments done. Presenter: Aswini K. Betha, PhD
  8. 8. What is needed for further development? • Determine long-term stability of the formulation. • Comprehensive testing of diverse gel formulations. • Testing in humans (clinical trials). • Looking for funding and research partners. • Technology available for licensing. Presenter: Aswini K. Betha, PhD